The Gross Margin of Mereo Biopharma Group PLC (MREO) is 74.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 74.26% |
| 2023-12-31 | 74.26% |
| 2022-12-31 | 50.89% |